Patient characteristics (N = 30)
| Characteristics | Data |
|---|---|
| Male, No. (%) | 25 (83.3) |
| Age (yr) | 71 ± 9 |
| Degree of stenosis % | 83 ± 9 |
| History | |
| Ischemic heart disease, No. (%) | 12 (40.0) |
| Hypertension, No. (%) | 21 (70.0) |
| Diabetes mellitus type 2, No. (%) | 12 (40.0) |
| Hyperlipidemia, No. (%) | 16 (53.3) |
| Smoking, No. (%) | 7 (23.3) |
| Medications | |
| Aspirin, No. (%) | 27 (90.0) |
| Ticlopidine, No. (%) | 1 (3.0) |
| Clopidogrel, No. (%) | 23 (76.7) |
| Cilostazol, No. (%) | 8 (26.7) |
| Statins, No. (%) | 19 (63.3) |
| Calcium channel blockers, No. (%) | 7 (23.3) |
| ARBs, No. (%) | 14 (46.7) |
| Laboratory parameters | |
| Total cholesterol (mg/dL) | 186 ± 31 |
| Triglycerides (mg/dL) | 145 ± 49 |
| HDL cholesterol (mg/dL) | 46 ± 11 |
| LDL cholesterol (mg/dL) | 112 ± 31 |
| C-reactive protein (mg/dL) | 0.21 ± 0.21 |
| Hemoglobin A1C (mg/dL) | 6.2 ± 1.1 |
Note:—ARBs indicates angiotensin II receptor blockers.